Thomas Cerny

Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group

Florian Strasser, Diana Lüftner, Kurt Possinger et al. · Journal of Clinical Oncology · 2006 · 402 citations · Full text

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

Daniel Betticher, Jim Heighway, P S Hasleton et al. · British Journal of Cancer · 1996 · 219 citations · Full text

Tumor Biology, Oncology, Non-small-cell Lung Cancer +11

Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group

Peter Borchmann, Heinz Haverkamp, Volker Diehl et al. · Journal of Clinical Oncology · 2011 · 186 citations

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.

Jens Dannull, P.A. Diener, Ladislav Prikler et al. · PubMed · 2000 · 144 citations

Histocompatibility, Cell Therapy, Immunology +18

Expression of epidermal growth factor receptor (EGF-R) in human lung tumours

Thomas Cerny, D M Barnes, P S Hasleton et al. · British Journal of Cancer · 1986 · 143 citations · Full text

Tumor Biology, Medicine, Pathology +9